Histopathological classification of cross-sectional image negative hyperaldosteronism
Author(s) -
Yuto Yamazaki,
Yasuhiro Nakamura,
Kei Omata,
Kazue Ise,
Yuta Tezuka,
Yoshikiyo Ono,
Ryo Morimoto,
Yukinaga Nozawa,
Celso E. Gómez-Sánchez,
Scott A. Tomlins,
William E. Rainey,
Sadayoshi Ito,
Fumitoshi Satoh,
Hironobu Sasano
Publication year - 2016
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2016-2986
Subject(s) - hyperaldosteronism , aldosterone synthase , aldosterone , germline mutation , hyperplasia , medicine , biology , pathology , immunohistochemistry , endocrinology , mutation , renin–angiotensin system , gene , genetics , blood pressure
Approximately half of patients with primary aldosteronism (PA) have clinically evident disease according to clinical (hypertension) and/or laboratory (aldosterone and renin levels) findings but do not have nodules detectable in routine cross-sectional imaging. However, the detailed histopathologic, steroidogenic, and pathobiological features of cross-sectional image-negative PA are controversial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom